89bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
89bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $10.10 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2021-11-12
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $10.10M.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $8.75M.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $10.72M.
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $11.54M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2021-09-30 | $10.10M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $8.75M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $10.72M 10-Q · filed 2021-05-14 |
| 2020-09-30 | $11.54M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $6.24M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $6.85M 10-Q · filed 2020-05-13 |